Get started
Economist

Long on ACAD - Upgraded Target to $35.00 level

Long
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)  
Economist  
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
0
0
This is more of a personal play as I have been long since the stock was trading below $3.00. There is a strong possibility this recent test of support, just below the $27.00 level, initiates the continuation of the price climb.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.